🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/07/2015 | 171,46 | 172,27 | 169,64 | 170,76 | -0,07% | 1,53% | 775.000 |
| 06/07/2015 | 169,21 | 172,15 | 168,31 | 170,88 | +0,45% | 2,27% | 936.700 |
| 02/07/2015 | 173,60 | 174,41 | 168,50 | 170,11 | -1,63% | 3,40% | 578.400 |
| 01/07/2015 | 175,87 | 176,14 | 172,57 | 172,93 | -0,59% | 2,03% | 630.400 |
| 30/06/2015 | 173,58 | 174,30 | 169,27 | 173,95 | +1,87% | 2,90% | 730.400 |
| 29/06/2015 | 173,90 | 176,17 | 170,47 | 170,75 | -2,67% | 3,28% | 627.100 |
| 26/06/2015 | 179,14 | 180,58 | 173,96 | 175,43 | -1,79% | 3,70% | 803.500 |
| 25/06/2015 | 177,45 | 179,89 | 175,33 | 178,63 | +0,72% | 2,57% | 612.800 |
| 24/06/2015 | 185,57 | 185,92 | 176,67 | 177,35 | -4,59% | 4,98% | 694.000 |
| 23/06/2015 | 189,86 | 189,87 | 185,25 | 185,89 | -1,34% | 2,43% | 498.800 |
| 22/06/2015 | 189,09 | 190,13 | 188,02 | 188,41 | +0,14% | 1,12% | 493.600 |
| 19/06/2015 | 186,50 | 189,19 | 183,93 | 188,15 | +1,28% | 2,82% | 761.000 |
| 18/06/2015 | 184,55 | 187,18 | 184,10 | 185,78 | +0,84% | 1,67% | 505.800 |
| 17/06/2015 | 187,16 | 187,87 | 183,45 | 184,23 | -1,43% | 2,36% | 395.300 |
| 16/06/2015 | 185,96 | 187,75 | 184,46 | 186,90 | +0,56% | 1,77% | 399.200 |
| 15/06/2015 | 185,57 | 187,51 | 182,67 | 185,85 | -0,70% | 2,61% | 629.600 |
| 12/06/2015 | 185,02 | 188,00 | 185,02 | 187,16 | +0,16% | 1,61% | 445.100 |
| 11/06/2015 | 182,15 | 186,99 | 181,48 | 186,87 | +2,73% | 3,02% | 468.800 |
| 10/06/2015 | 178,37 | 183,40 | 176,58 | 181,90 | +2,12% | 3,82% | 433.500 |
| 09/06/2015 | 181,16 | 181,98 | 176,32 | 178,12 | -1,60% | 3,12% | 436.000 |
| 08/06/2015 | 180,32 | 182,53 | 180,32 | 181,02 | -0,18% | 1,23% | 567.600 |
| 05/06/2015 | 180,00 | 182,54 | 178,10 | 181,35 | +0,92% | 2,47% | 361.100 |
| 04/06/2015 | 181,93 | 184,26 | 178,68 | 179,70 | -2,33% | 3,07% | 464.100 |
| 03/06/2015 | 183,00 | 186,56 | 181,20 | 183,98 | +1,13% | 2,93% | 432.100 |
| 02/06/2015 | 181,29 | 183,95 | 179,92 | 181,92 | -0,15% | 2,22% | 464.200 |
| 01/06/2015 | 184,72 | 185,04 | 180,28 | 182,19 | -0,83% | 2,58% | 507.400 |
| 29/05/2015 | 182,10 | 184,50 | 180,33 | 183,72 | +1,03% | 2,29% | 2.466.200 |
| 28/05/2015 | 182,60 | 186,24 | 179,32 | 181,85 | -0,88% | 3,79% | 506.100 |
| 27/05/2015 | 183,57 | 186,52 | 182,61 | 183,46 | +0,53% | 2,13% | 610.900 |
| 26/05/2015 | 183,47 | 186,43 | 180,22 | 182,50 | -0,65% | 3,38% | 765.500 |